Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2003 2
2004 7
2005 5
2006 8
2007 6
2008 5
2009 6
2010 12
2011 5
2012 7
2013 9
2014 11
2015 20
2016 18
2017 21
2018 27
2019 11
2020 35
2021 42
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

227 results
Results by year
Filters applied: . Clear all
Page 1
[COVID-19: Still a place for tocilizumab?].
Richier Q, Plaçais L, Lacombe K, Hermine O. Richier Q, et al. Among authors: lacombe k. Rev Med Interne. 2021 Feb;42(2):73-78. doi: 10.1016/j.revmed.2020.11.016. Epub 2020 Nov 27. Rev Med Interne. 2021. PMID: 33288230 Free PMC article. Review. French. No abstract available.
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.
Hueso T, Pouderoux C, Péré H, Beaumont AL, Raillon LA, Ader F, Chatenoud L, Eshagh D, Szwebel TA, Martinot M, Camou F, Crickx E, Michel M, Mahevas M, Boutboul D, Azoulay E, Joseph A, Hermine O, Rouzaud C, Faguer S, Petua P, Pommeret F, Clerc S, Planquette B, Merabet F, London J, Zeller V, Ghez D, Veyer D, Ouedrani A, Gallian P, Pacanowski J, Mékinian A, Garnier M, Pirenne F, Tiberghien P, Lacombe K. Hueso T, et al. Among authors: lacombe k. Blood. 2020 Nov 12;136(20):2290-2295. doi: 10.1182/blood.2020008423. Blood. 2020. PMID: 32959052 Free PMC article.
Reply.
Boyd A, Peytavin G, Lacombe K. Boyd A, et al. Among authors: lacombe k. Hepatology. 2016 Sep;64(3):1000-1. doi: 10.1002/hep.28463. Epub 2016 Mar 7. Hepatology. 2016. PMID: 26784682 No abstract available.
A look-back at convalescent plasma to treat COVID-19.
Garraud O, Lacombe K, Tiberghien P. Garraud O, et al. Among authors: lacombe k. Transfus Apher Sci. 2021 Feb;60(1):103063. doi: 10.1016/j.transci.2021.103063. Epub 2021 Jan 12. Transfus Apher Sci. 2021. PMID: 33478889 Free PMC article. Review. No abstract available.
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Ader F, Peiffer-Smadja N, Poissy J, Bouscambert-Duchamp M, Belhadi D, Diallo A, Delmas C, Saillard J, Dechanet A, Mercier N, Dupont A, Alfaiate T, Lescure FX, Raffi F, Goehringer F, Kimmoun A, Jaureguiberry S, Reignier J, Nseir S, Danion F, Clere-Jehl R, Bouiller K, Navellou JC, Tolsma V, Cabié A, Dubost C, Courjon J, Leroy S, Mootien J, Gaci R, Mourvillier B, Faure E, Pourcher V, Gallien S, Launay O, Lacombe K, Lanoix JP, Makinson A, Martin-Blondel G, Bouadma L, Botelho-Nevers E, Gagneux-Brunon A, Epaulard O, Piroth L, Wallet F, Richard JC, Reuter J, Staub T, Lina B, Noret M, Andrejak C, Lê MP, Peytavin G, Hites M, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy study group. Ader F, et al. Among authors: lacombe k. Clin Microbiol Infect. 2021 Dec;27(12):1826-1837. doi: 10.1016/j.cmi.2021.05.020. Epub 2021 May 26. Clin Microbiol Infect. 2021. PMID: 34048876 Free PMC article. Clinical Trial.
Tocilizumab in Coronavirus Disease 2019: Give It Time!
Richier Q, Plaçais L, Lacombe K, Hermine O. Richier Q, et al. Among authors: lacombe k. Clin Infect Dis. 2021 Dec 16;73(12):2368-2369. doi: 10.1093/cid/ciab081. Clin Infect Dis. 2021. PMID: 33515253 Free PMC article. No abstract available.
Immune interventions in COVID-19: a matter of time?
Plaçais L, Richier Q, Noël N, Lacombe K, Mariette X, Hermine O. Plaçais L, et al. Among authors: lacombe k. Mucosal Immunol. 2021 Oct 28:1-13. doi: 10.1038/s41385-021-00464-w. Online ahead of print. Mucosal Immunol. 2021. PMID: 34711920 Free PMC article. Review.
227 results